Lessons learned from a highly-active CD22-specific chimeric antigen receptor

Por Long, Adrienne H., Haso, Waleed M., Orentas, Rimas J.
Publicado em 2013

Enhanced glycolytic metabolism is associated with exhaustion and poor antitumor efficacy in a xenograft model of chimeric antigen receptor T cell therapy for sarcoma

Por Long, Adrienne H, Orentas, Rimas J, Mackall, Crystal L
Publicado em 2013

TMIC-08 EXTRANEURAL METASTASIS OF HIGH-GRADE GLIOMAS: SYSTEMATIC REVIEW OF LITERATURE AND A DISCUSSION OF THE IMMUNE SYSTEM ROLE IN GLIOMA GROWTH

Por Daher, Ahmad, Lukas, Rimas, Pytel, Peter, Nicholas, Martin Kelly
Publicado no Neuro Oncol (2015)

Updates from the Neuro-Oncology Section of the 2015 American Neurological Association Annual Meeting

Por Lukas, Rimas V, Wainwright, Derek A, Laterra, John J
Publicado no Future Oncol (2016)

Targeted therapy in the treatment of malignant gliomas

Por Rimas V Lukas, Adrienne Boire, M Kelly Nicholas
Publicado em 2009-05-01

Transduction of Primary Lymphocytes with Epstein-Barr Virus (EBV) Latent Membrane Protein-Specific T-Cell Receptor Induces Lysis of Virus-Infected Cells: A Novel Strategy for the T...

Por Jurgens, Lisa A., Khanna, Rajiv, Weber, James, Orentas, Rimas J.
Publicado em 2006

Adaptive aberration correction in a confocal microscope

Por Booth, Martin J., Neil, Mark A. A., Juškaitis, Rimas, Wilson, Tony
Publicado em 2002

Accrediting Neurology Fellowships Accelerates Subspecialization

Por Hodgson, Trent S., Brorson, James R., Ardelt, Agnieszka A., Lukas, Rimas V.
Publicado em 2013

Modeling the hospital safety partnership preferences of patients and their families: a discrete choice conjoint experiment

Por Cunningham, Charles E, Hutchings, Tracy, Henderson, Jennifer, Rimas, Heather, Chen, Yvonne
Publicado no Patient Prefer Adherence (2016)

Understanding academic clinicians’ intent to treat pediatric obesity

Por Frankfurter, Claudia, Cunningham, Charles, Morrison, Katherine M, Rimas, Heather, Bailey, Karen
Publicado no World J Clin Pediatr (2017)

ModA and ModB, Two ADP-Ribosyltransferases Encoded by Bacteriophage T4: Catalytic Properties and Mutation Analysis

Por Tiemann, Bernd, Depping, Reinhard, Gineikiene, Egle, Kaliniene, Laura, Nivinskas, Rimas, Rüger, Wolfgang
Publicado em 2004

Student assessment by objective structured examination in a neurology clerkship

Por Lukas, Rimas V., Adesoye, Taiwo, Smith, Sandy, Blood, Angela, Brorson, James R.
Publicado em 2012

Expression of Macrophage Migration Inhibitory Factor (MIF) by Neuroblastoma Leads to the Inhibition of Anti-Tumor T Cell Reactivity In Vivo()

Por Zhou, Qiang, Yan, Xiaocai, Gershan, Jill, Orentas, Rimas J., Johnson, Bryon D.
Publicado em 2008

ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors

Por Orentas, Rimas J, Lopomo, Paola, Babbitt, William, Vigny, Marc, Mackall, Crystal L
Publicado em 2013

Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors

Por Highfill, Steven L, Long, Adrienne H, Orentas, Rimas J, Mackall, Crystal L
Publicado em 2013

Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)

Por Walker, Alec, Lopomo, Paola, Babbitt, William, Vigny, Marc, Mackall, Crystal, Orentas, Rimas
Publicado no J Immunother Cancer (2014)

Neurology objective structured clinical examination reliability using generalizability theory

Por Blood, Angela D., Park, Yoon Soo, Lukas, Rimas V., Brorson, James R.
Publicado no Neurology (2015)

Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)

Por Schneider, Dina, Xiong, Ying, Roy, Andre, Kaiser, Andrew, Dropulic, Boro, Orentas, Rimas
Publicado no J Immunother Cancer (2015)

State-of-the-art considerations in small cell lung cancer brain metastases

Por Lukas, Rimas V., Gondi, Vinai, Kamson, David O., Kumthekar, Priya, Salgia, Ravi
Publicado no Oncotarget (2017)

Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases

Por Lukas, Rimas V, Nicholas, Martin Kelly, Villaflor, Victoria, Hoffman, Philip C., Salgia, Ravi
Publicado em 2012